Boram Kim

Boram Kim

Auto-generated profile, based on publicly available information

Boram Kim

Department of Bioengineering, Rice University, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2023 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
SMSudip Mukherjee
Sudip Mukherjee
BKBoram Kim
Boram Kim
LCLauren Y. Cheng
Lauren Y. Cheng
MDMichael David Doerfert
Michael David Doerfert
JLJiaming Li
Jiaming Li
OVOmid Veiseh
Omid Veiseh

26 June 2021 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
SASamira Aghlara-Fotovat
Samira Aghlara-Fotovat
ANAmanda Nash
Amanda Nash
BKBoram Kim
Boram Kim
RKRobert Krencik
Robert Krencik
OVOmid Veiseh
Omid Veiseh

14 November 2022 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
MCMaria Chen
Maria Chen
BKBoram Kim
Boram Kim
MJMaria I. Jarvis
Maria I. Jarvis
SFSamantha Fleury
Samantha Fleury
SDShuyun Deng
Shuyun Deng
OVOmid Veiseh
Omid Veiseh

7 August 2026 in Science Advances
Verified
Journal Article
Open access
BKBoram Kim
Boram Kim
DVDilrasbonu Vohidova
Dilrasbonu Vohidova
ANAmanda Nash
Amanda Nash
YCYuen San Chan
Yuen San Chan
SFSamantha Fleury
Samantha Fleury
OVOmid Veiseh
Omid Veiseh
The efficacy of cell-based therapeutics is often compromised by host immune recognition of implanted cells and biomaterials, resulting in fibrotic encapsulation and loss of function. Here, we address this challenge with an immunomodulatory cell-based therapy, in which alginate-encapsulated retinal pigment epithelial cells continuously secrete cytokines to locally modulate the implant microenvironment. In a healthy rodent model, the localized production of interleukin-10 (IL-10) or IL-12 from encapsulated cytokine-producing cells prevented foreign body response to alginate capsules. Mechanistically, treatment was associated with reduced expression of profibrotic genes and immune shifts consistent with macrophage and T cell regulation, supporting a cytokine-mediated mitigation of foreign body response. In a diabetic murine model (streptozotocin-induced C57BL/6J), coimplantation of human islets with IL-10–producing cells attenuated pericapsular fibrosis, preserved islet viability, and restored normoglycemia for up to 100 days (4.76 times longer than islets alone). Notably, IL-10–producing cells were also effective in enabling the durability and function of encapsulated cells in a healthy nonhuman primate, showing translational feasibility. Collectively, these findings suggest that localized cytokine delivery can reduce fibrotic encapsulation and support durable graft function, offering a path to lessen reliance on systemic immunosuppression in islets transplantation and other implantable biomaterial therapies.

11 October 2024 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
BKBoram Kim
Boram Kim
JSJoseph W. R. Swain
Joseph W. R. Swain
MFMartha J. Fowler
Martha J. Fowler
CYClaire Y. Yang
Claire Y. Yang
DVDilrasobonu Vohidona
Dilrasobonu Vohidona
OVOmid Veiseh
Omid Veiseh
Effective vascularization is crucial for repairing and enhancing the longevity of engineered tissues and organs. As the field advances, there is a vital need for efficient and reliable methods for assessing vascularization in real-time. The integration and performance of constructed biomaterials in living organisms rely on angiogenesis and vascularization, making it essential to evaluate vascular development and networks within biomaterials. Current histology-based methods are limited and labor-intensive. On the other hand, fluorescence imaging offers promise for efficient, real-time evaluation of angiogenesis, reducing the time needed for screening many compounds and offering a high-throughput alternative to histology-based methods. Here, we investigated a novel, non-invasive method for quick and repeated analysis of the angiogenic and vascularization process in biomaterials via fluorescence IVIS imaging. Multi-domain peptides (MDPs), self-assembling peptide hydrogels that can possess pro-angiogenic properties depending on their primary sequence, were synthesized and utilized as angiogenic biomaterials and screened with a fluorescence IVIS probe to demonstrate real-time rapid angiogenesis in vivo. The fluorescence-based imaging showed the influence of the peptide chemistry, volume, and concentration on angiogenesis, with one particular MDP, SLanc, promoting robust angiogenesis after one week at 2 w/v%. Through this method, we were able to identify the optimal peptide for rapid and sustained angiogenesis. This approach enables real-time monitoring of angiogenic responses and vascularization processes in the same living subject. It promotes the development of new biomaterials that facilitate vascularization and validates an advanced in vivo screening technique for angiogenesis.